136 related articles for article (PubMed ID: 32252782)
1. Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly.
Zhou Z; Sun M; Jin H; Chen H; Ju H
Lipids Health Dis; 2020 Apr; 19(1):61. PubMed ID: 32252782
[TBL] [Abstract][Full Text] [Related]
2. Fetuin-A to adiponectin ratio is an independent indicator of subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes mellitus.
Zhou Z; Chen H; Sun M; Jin H; Ju H
J Diabetes Complications; 2022 Jan; 36(1):108102. PubMed ID: 34887185
[TBL] [Abstract][Full Text] [Related]
3. Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese.
Xu Y; Xu M; Bi Y; Song A; Huang Y; Liu Y; Wu Y; Chen Y; Wang W; Li X; Ning G
Atherosclerosis; 2011 May; 216(1):180-6. PubMed ID: 21310413
[TBL] [Abstract][Full Text] [Related]
4. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
5. Serum fetuin-A and arginase-1 in human obesity model: Is there any interaction between inflammatory status and arginine metabolism?
Tanrikulu-Küçük S; Koçak H; Öner-İyidoğan Y; Seyithanoğlu M; Topparmak E; Kayan-Tapan T
Scand J Clin Lab Invest; 2015 Jul; 75(4):301-7. PubMed ID: 25723054
[TBL] [Abstract][Full Text] [Related]
6. Serum adiponectin and fetuin-A levels in children with nephrotic syndrome.
El-Mashad GM; Essa SM
Egypt J Immunol; 2011; 18(1):17-23. PubMed ID: 23082476
[TBL] [Abstract][Full Text] [Related]
7. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.
Stefan N; Sun Q; Fritsche A; Machann J; Schick F; Gerst F; Jeppesen C; Joost HG; Hu FB; Boeing H; Ullrich S; Häring HU; Schulze MB
PLoS One; 2014; 9(3):e92238. PubMed ID: 24643166
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: A prospective study.
Karampela I; Kandri E; Antonakos G; Vogiatzakis E; Christodoulatos GS; Nikolaidou A; Dimopoulos G; Armaganidis A; Dalamaga M
J Crit Care; 2017 Oct; 41():78-85. PubMed ID: 28500919
[TBL] [Abstract][Full Text] [Related]
10. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
11. Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes.
Jung CH; Kim BY; Kim CH; Kang SK; Jung SH; Mok JO
Diab Vasc Dis Res; 2013 Sep; 10(5):459-67. PubMed ID: 23811603
[TBL] [Abstract][Full Text] [Related]
12. Higher fetuin-A level is associated with coexistence of elevated alanine aminotransferase and the metabolic syndrome in the general population.
Koch M; Jacobs G; Hampe J; Rosenstiel P; Krawczak M; Nöthlings U
Metab Syndr Relat Disord; 2013 Dec; 11(6):377-84. PubMed ID: 23971757
[TBL] [Abstract][Full Text] [Related]
13. Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study.
Ju H; Zhou Z; Sun M; Chen H
Endocrine; 2017 Oct; 58(1):190-193. PubMed ID: 28779425
[No Abstract] [Full Text] [Related]
14. Multiplexed measurements of salivary fetuin-A, insulin, and adiponectin as potential non-invasive biomarkers in childhood obesity.
Selvaraju V; Babu JR; Geetha T
Cytokine; 2022 May; 153():155843. PubMed ID: 35255380
[TBL] [Abstract][Full Text] [Related]
15. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
16. The relationship between serum fetuin-A, cystatin-C levels, and microalbuminuria in patients with metabolic syndrome.
Huddam B; Azak A; Koçak G; Bayraktar N; Sezer S
J Clin Lab Anal; 2013 Jul; 27(4):317-22. PubMed ID: 23852792
[TBL] [Abstract][Full Text] [Related]
17. Fetuin-A levels in lean and obese women with polycystic ovary syndrome.
Kozakowski J; Jeske W; Zgliczyński W
Endokrynol Pol; 2014; 65(5):371-6. PubMed ID: 25301487
[TBL] [Abstract][Full Text] [Related]
18. Both diabetes and fetuin-A are independently associated with increased risk of arterial stiffness.
Ou HY; Lu FH; Wu HT; Hung HC; Wu JS; Yang YC; Chang CJ
Clin Chim Acta; 2015 May; 445():133-8. PubMed ID: 25841642
[TBL] [Abstract][Full Text] [Related]
19. Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.
Okamoto T; Tsutaya C; Hatakeyama S; Konishi S; Okita K; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
Int Urol Nephrol; 2018 Sep; 50(9):1713-1720. PubMed ID: 30128921
[TBL] [Abstract][Full Text] [Related]
20. Fetuin-A is also an adipokine.
Jialal I; Pahwa R
Lipids Health Dis; 2019 Mar; 18(1):73. PubMed ID: 30917813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]